Related Experiment Video
Updated: Aug 10, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
[Sensitivity of fungi in the genus Candida to antimicrobial preparations]
Abstract:
Sensitivity of 50 Candida fungus strains isolated from patients with chronic intestine diseases was studied with respect to amphotericin B, levorin, enteroseptol, intestopan and decamethoxin. The rate of forming resistant variants of the strains with respect to decamethoxin and development of their cross resistance to levorin was estimated. It was shown that decamethoxin was the most active antifungal drug among the drugs tested. Estimation of sensitivity of the Candida strains to enteroseptol and intestopan revealed that the fungicidal concentration of enteroseptol for 78 per cent of the strains ranged within 3.9-7.8 micrograms/ml. It was demonstrated that development of resistance to decamethoxin in the strains of Candida albicans was slow and did not reach high levels. No cross resistance between decamethoxin and levorin was detected.
Insights
Decamethoxin demonstrated superior antifungal activity against Candida strains from chronic intestinal diseases. Resistance to decamethoxin developed slowly, with no cross-resistance observed with levorin.
Area of Science:
- Medical Mycology
- Antimicrobial Resistance
Background:
- Candida species are opportunistic fungal pathogens.
- Chronic intestinal diseases can predispose individuals to Candida infections.
- Effective antifungal agents are crucial for managing these infections.
Purpose of the Study:
- To evaluate the antifungal sensitivity of Candida strains isolated from patients with chronic intestinal diseases.
- To assess the development of resistance to decamethoxin and cross-resistance to levorin.
Main Methods:
- Testing the sensitivity of 50 Candida strains to amphotericin B, levorin, enteroseptol, intestopan, and decamethoxin.
- Estimating the rate of resistant variant formation against decamethoxin.
- Assessing cross-resistance development between decamethoxin and levorin.
Main Results:
- Decamethoxin exhibited the highest antifungal activity among the tested drugs.
- The fungicidal concentration of enteroseptol ranged from 3.9-7.8 µg/ml for 78% of strains.
- Candida albicans developed resistance to decamethoxin slowly, without reaching high levels.
- No cross-resistance was detected between decamethoxin and levorin.
Conclusions:
- Decamethoxin is a highly effective antifungal agent against Candida strains from chronic intestinal diseases.
- The slow development of resistance and lack of cross-resistance suggest decamethoxin's potential for sustained therapeutic use.
- Enteroseptol and intestopan also showed significant fungicidal activity, warranting further investigation.
Related Concept Videos
Antimicrobial Effectiveness
Cryptococcal Meningitis
Candidiasis
Antifungal Agents

